Medivir amends terms of cold sores drug pact with Meda
As per the terms of the amended agreement, Meda will be responsible to pay a sum of $45m to Medivir for transferring of all rights to the product
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
Tibotec will be responsible for the formulation, manufacturing, registration, distribution and commercialization of the cobicistat and Prezista fixed-dose combination worldwide. Gilead is responsible to develop, manufacture and commercialize
Using Xerox’s Communication and Marketing Services, Medco provides 65 million members the ability to personalize their prescription drug management information and communication delivery channels. This multi-channel communications approach
Sherpa Clinical Packaging provides clinical trial material management services, including packaging, labeling, distribution and returns reconciliation, for pharmaceutical, biotechnology, medical device, in-vitro diagnostics and dietary supplement companies. The